The Advertising Categories Where Getting Approved Is Harder Than Getting Results with Shane Ginsberg, Founder of Street Poller Media

Most advertising discussions assume the difficult part is performance. In several of the fastest-growing categories in digital marketing, performance has become the second problem. The first is whether the advertisement runs at all.

Platform compliance regimes have tightened substantially over the past two years, and the tightening has been formal rather than incidental. Meta’s requirements around cryptocurrency advertising expanded through 2025 and into 2026, introducing tiered authorization structures requiring regulatory licensing documentation before campaigns can launch. Financial categories broadly now carry among the highest ad account restriction rates on the platform. TikTok maintains a restricted-industry list spanning gambling and sports betting, cryptocurrency, financial services, and weight-loss and supplement products, each with distinct pre-approval workflows, documentation requirements, and geographic limitations.

The practical result is that polished, claims-heavy creative, precisely what these categories historically relied upon, has become among the hardest material to get approved.

That environment has created demand for a category of expertise that did not previously command a premium. Street Poller Media has operated continuously across crypto, fintech, GLP-1, pharmaceutical, and cannabis-adjacent brands that many creative agencies decline entirely, and founder Shane Ginsberg has pointed to two factors behind that capability.

The first is accumulated platform relationships. Sustained operation in restricted categories means ongoing direct contact with the platforms, which matters in an environment where enforcement frequently diverges from written policy and where knowing how a rule is applied is materially different from knowing how it is worded.

The second factor is structural rather than relational, and it concerns the format itself. A street interview does not read as an overt sales pitch the way produced, claims-driven advertising does. It resembles a conversation more than a commercial, which has consequences during review, because a substantial share of what triggers rejection in regulated categories is not the product being advertised but the specific assertions being made about it. A person describing their own experience is making a personal statement. A brand asserting an outcome is making a claim, and claims are what compliance systems exist to evaluate.

The stakes attached to getting this wrong extend past a delayed campaign. A disabled advertising account can mean losing accumulated pixel data, audience targeting history, and optimization signal built over months, which represents a considerably larger setback than the immediate media spend involved. For a brand operating at scale, account termination in a restricted category can set acquisition back a full quarter.

That risk profile changes what brands in these categories are actually shopping for. The question is no longer which creative approach a marketing team prefers or is equipped to produce. It has become which formats consistently clear review, and which partners have run enough campaigns in a given restricted vertical to know in advance which questions, phrasings, and structures survive and which reliably do not.

Ginsberg’s argument is that this represents an operational advantage rather than a creative one, which is a more honest framing than most agency positioning offers. Any competent production team can film a street interview. Considerably fewer have run enough campaigns across crypto, GLP-1, and cannabis-adjacent categories to have developed a working sense of where the enforcement lines actually sit.

There is a second-order effect worth noting. Because compliance expertise in these verticals is scarce and slow to build, it functions as a partial barrier to entry in exactly the categories with the largest advertising budgets. A newer agency can replicate the creative format within weeks. Developing a reliable sense of what clears review in pharmaceutical or cannabis-adjacent advertising requires running campaigns, absorbing rejections, and occasionally losing accounts, which is an expensive education that clients ultimately finance.

That dynamic explains why several of the most restricted categories have consolidated around a small number of specialist partners rather than distributing across the broader agency market, a pattern more familiar from regulated professional services than from creative advertising.

For brands in categories where the regulatory direction continues tightening rather than loosening, that accumulated knowledge has become harder to source than creative talent, and considerably more expensive to acquire the hard way.